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Botanically derived natural products have recently become an attractive source of new chemotherapeutic agents. To explore active anticolorectal cancer compounds, we carried out phytochemical studies on Alkanna tinctoria and isolated eight quinone compounds. Using different spectral methods, compounds were identified as alkannin (1) , acetylalkannin (2) , angelylalkannin (3), 5-methoxyangenylalkannin (4), dimethylacryl alkannin (5) , arnebifuranone (6) , alkanfuranol (7) , and alkandiol (8) . Compounds 4, 7, and 8 are novel compounds. The structures of the three novel compounds were elucidated on the basis of extensive spectroscopic evidence including high-resolution mass spectrometry and nuclear magnetic resonance spectra. The antiproliferative effects of these eight compounds on HCT-116 and SW-480 human colorectal cancer cells were determined using the MTS method. Cell cycle and apoptosis were determined using flow cytometry. Enzymatic activities of caspases were determined using a colorimetric assay, and interactions of compound 4 and caspase 9 were explored by docking analysis. Among the eight compounds, alkannin (1), angelylalkannin (3), and 5-methoxyangenylalkannin (4) showed strong antiproliferative effects, whereas compound 4 showed the most potent effects. Compound 4 arrested cancer cells in the S and G2/M phases, and significantly induced cell apoptosis. The apoptotic effects of compound 4 were supported by caspase assay and docking analysis. The structural-functional relationship assay suggested that to increase anticancer potential, future modifications on alkannin (1) should focus on the hydroxyl groups at C-5 and C-8. 
Introduction
Alkanna tinctoria (L.) Tausch is distributed widely in Europe and western Asia. Its root has been used as a botanical drug for ulcers, inflammation, and wounds [1] . Previous phytochemical studies on this plant have resulted in the isolation of a series of naphthoquinone pigments, including alkannin and its derivatives [2] [3] [4] [5] . Some of these compounds show biological properties such as cytotoxic, antimicrobial, antileishmanial, and antiinflammatory activities [6, 7] . In our previous study, we isolated two known naphthoquinone compounds from this plant and observed their antiproliferative effects on human colorectal cancer cells [8] .
In this study, we performed a systemic phytochemical isolation on A. tinctoria. Eight quinone compounds were isolated and their chemical structures were elucidated using different spectral methods. Among the eight compounds, three novel compounds were characterized. The antiproliferative effects of the eight compounds on human colorectal cancer cells were determined. The effects of these compounds on the cell cycle and apoptosis were evaluated. To further explore the potential mechanisms of apoptosis, a structure-based docking model was simulated to gain insights into ligand-receptor interaction. One novel alkannin derivative showed the most potent antiproliferative effect, and the structural-functional relationship of these naphthoquinone compounds was explored.
Materials and methods

Chemicals and reagents
All solvents were of high-performance liquid chromatography grade (Wako Pure Chemicals, Osaka, Japan). Materials for column chromatography included silica gel 60 (230-400 mesh; Nacalai Tesque Inc., Kyoto, Japan), YMC ODS-A gel (50 mm; YMC Co. Ltd., Kyoto, Japan), and Sephadex LH-20 gel (Pharmacia Biotech, Uppsala, Sweden). Thin layer chromatography was performed on Kieselgel 60 F 254 (Merck, Damstadt, Germany) plates. Milli-Q water was supplied by a water purification system (US Filter, Palm Desert, California, USA). All cell culture plasticware was obtained from Falcon Labware (Franklin Lakes, New Jersey, USA) and Techno Plastic Products (Trasadingen, Switzerland). Trypsin, McCoy's 5A and Leibovitz's L-15 media, and PBS were obtained from Mediatech Inc. (Herndon, Virginia, USA). Penicillin and streptomycin were obtained from Sigma-Aldrich (St Louis, Missouri, USA). An MTS assay kit, CellTiter 96 Aqueous Solution Cell Proliferation Assay, was obtained from Promega (Madison, Wisconsin, USA). Propidium iodide (PI)/RNase staining buffer was obtained from BD Biosciences Pharmingen (San Diego, California, USA). An annexin V-fluorescein isothiocyanate apoptosis detection kit was obtained from BD Biosciences (Rockville, Maryland, USA). Caspase 3, 8, and 9 kits were obtained from BioVison (Mountain View, California, USA).
Instrument procedures for structure elucidation
Optical rotations were obtained using a DIP-360 digital polarimeter (Jasco, Easton, Maryland, USA). Nuclear magnetic resonance (NMR) spectra were recorded on a JEOL ECX 400 NMR spectrometer (JEOL, Tokyo, Japan). ESI-TOFMS experiments utilized a JEOLAccu-TOF TM LC 1100 mass spectrometer (JEOL).
Plant materials
Dried roots of A. tinctoria (L.) Tausch (Boraginaceae) were donated by Professor Tibor Wenger, Semmelweis University, Budapest, Hungary, and authenticated by Professor Yukihiro Shoyama. A voucher specimen (Number 201112) was deposited at the Herbarium of Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki, Japan.
Extraction, isolation, and structure elucidation A total of 900 g of air-dried A. tinctoria root powder was extracted with 95% EtOH to obtain 35 g of EtOH extract. The EtOH extract was suspended in H 2 O and partitioned with CHCl 3 to obtain 14 g of CHCl 3 -soluble pigment fraction. The pigment fraction was then fractionated on a silica gel column with a gradient of hexane-EtOAc (20 : 1-0 : 1, v/v) to obtain five fractions (fr.1.1-1.5). Fr.1.1 (2100 mg) was chromatographed repeatedly on a silica gel column with hexane-EtOAc (20 : 1), followed by a Sephadex LH-20 column with MeOH as an eluent to obtain 3 (950 mg). Fr.1.2 (450 mg) was chromatographed repeatedly on a silica gel column with hexane-EtOAc (10 : 1, v/v), followed by a Sephadex LH-20 column with MeOH as an eluent to obtain 2 (20 mg). Fr.1.3 (1700 mg) was subjected to a silica gel column with hexane-EtOAc (5 : 1, v/v), followed by a Sephadex LH-20 column with MeOH as an eluent to yield 4 (15 mg) and 8 (20 mg). Similarly, fr.1.4 (610 mg) was loaded onto a silica gel column with hexane-EtOAc (5 : 1 and 4 : 1, v/v) and then followed by Sephadex LH-20 chromatography with MeOH as an eluent to yield 1 (25 mg), 6 (10 mg), and 7 (15 mg). Finally, compound 5 (8 mg) was isolated from fr. 1.5 (300 mg) by reversephase column chromatography with MeOH-H 2 O (3 : 1, v/v) and preparative thin layer chromatography with hexane-EtOAc (2 : 1, v/v). Spectral data of novel compounds, 4, 7, and 8 are included in the following paragraphs. The amounts of purified compounds are 8-950 mg. Thus, the percentage of isolated compounds in relation to plant materials is between 0.0009 and 0.106%. 
5-Methoxyangenylalkannin
Cell culture
Human colorectal cancer cell lines HCT-116 (McCoy's 5A) and SW-480 (Leibovitz's L-15) were obtained from the American Type Culture Collection (Manassas, Virginia, USA). Cells were grown in the indicated medium supplemented with 10% fetal bovine serum and 50 IU penicillin/streptomycin in a humidified atmosphere with 5% CO 2 at 371C.
Cell proliferation analysis
Compounds 1-8 were dissolved in dimethyl sulfoxide (DMSO) and were stored at -201C before use. Cells were seeded in 96-well plates (1 Â 10 4 cells/well). After 24 h, indicated concentrations of drugs were added to the wells. The final concentration of DMSO was 1%. Controls were exposed to culture medium containing 1% DMSO without drugs. All experiments were conducted in triplicate. Following the indicated incubation period, cell proliferation was evaluated using an MTS assay according to the manufacturer's instructions. Briefly, the medium was replaced with 100 ml of fresh medium and 20 ml of MTS reagent (CellTiter 96 Aqueous Solution) in each well, and the plate was returned to the incubator for 1-2 h. A 60 ml aliquot of medium from each well was transferred to an enzyme-linked immunosorbent assay 96-well plate and its absorbance at 490 nm was recorded. As 1% DMSO did not influence the proliferation of the two cell lines, results were expressed as percent of control (DMSO vehicle set at 100%).
Cell cycle assay
Cells were seeded into 24-well tissue culture plates. On the second day, the medium was changed and cells were treated with test compounds. Cells were incubated for 48 h before they were harvested. These cells were fixed gently with 80% ethanol in a freezer for 2 h and were then treated with 0.25% Triton X-100 for 5 min in an ice bath. Cells were resuspended in 300 ml of PBS containing 40 mg/ml PI and 0.1 mg/ml RNase. Then, the cells were incubated in a dark room for 20 min at room temperature, and cell cycle analysis was carried out using a FACScan flow cytometer (Becton Dickinson, Mountain View, California, USA) and FlowJo 7.1.0 software (Tree Star, Ashland, Oregon, USA). For each measurement, at least 10 000 cells were counted.
Apoptotic analysis
Cell apoptosis was assayed by flow cytometry following a previously described procedure [9] . Briefly, after treatment for 48 h, cells floating in the medium were collected. The adherent cells were detached with trypsin. Then, culture medium containing 10% fetal bovine serum (and floating cells) was added to inactivate trypsin. After gentle pipetting, the cells were centrifuged for 5 min at 1500g. The supernatant was removed and cells were stained with annexin V-fluorescein isothiocyanate and PI according to the manufacturer's instructions. Untreated cells served as a control. The cells were analyzed immediately after staining using a flow cytometer. For each measurement, at least 20 000 cells were counted.
Caspase 3 and 9 assays
SW-480 cells were seeded in six-well tissue culture plates. After 24 h, the medium was changed and compound 4 was added. After treatment for 24 h, cell lysates were collected. Expression levels of caspases 3 and 9 were determined using the colorimetric method according to the manufacturer's instructions. Briefly, cell lysates were diluted with 50 ml of 2 Â reaction buffer (containing 10 mmol/l dithiothreitol) to a protein concentration of 0.5 mg/ml in an enzyme-linked immunosorbent assay 96well plate. Then, 5 ml of colorimetric tetrapeptide substrate (DEVD-pNA for caspase 3 and LEHDpNA for caspase 9) and cell lysate were added, and the plate was incubated at 371C for 24 h. Absorbance was recorded at 405 nm. The change in caspase activity was calculated as absorbance of compound 4-treated cells/absorbance of untreated controls.
Western blot analysis SW-480 cells were collected 24 h after exposure to 1-15 mmol/l of compound 4 or vehicle and then lysed in a cold radioimmunoprecipitation assay buffer supplemented with 1% (v/v) protease inhibitor cocktail, and stored in aliquots at -801C for later analysis. The protein concentration of the samples was determined using a BCA protein assay kit (Pierce, Rockford, Illinois, USA). Lysates (40 mg protein) were denatured by heating at 951C for 10 min and loaded on 4-15% Mini-PROTEAN TGX precast gels (Bio-Rad, Hercules, California, USA) for electrophoresis. Then, the proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad) and blocked in PBST buffer (PBS with 0.05% Tween 20) containing 5% nonfat dried milk. The blots were incubated with the indicated primary antibodies (p21 waf1/cip1 , cdc2, cyclin B1, cdk2, caspase 3, caspase 9, and b-actin, from Cell Signaling, Danvers, Massachusetts, USA) overnight at 41C, followed by incubation for 1 h with the appropriate secondary antibodies conjugated with horseradish peroxidase in blocking buffer. b-Actin was measured as the loading control. Immunocomplexes were detected using Super Signal West Pico Substrate (Thermo-pierce, Rockford, Illinois, USA) following the manufacturer's directions and quantified by densitometry using Image J software (National Institutes of Health, Bethesda, Maryland, USA). Intensities were normalized to vehicle-treated samples after adjusting for b-actin loading.
Receptor docking analysis
The possible binding modes of compound 4 at the catalytic domains of human caspase 9 were predicted using the docking program Surflex-Dock (Tripos, St Louis, Missouri, USA). The structure of compound 4 was generated (through Ligand model in Sybyl) and the protein crystal structure of caspase 9 was obtained (PDB code 2AR9). For preparation for the docking analysis, the protein structure was prepared by adding hydrogen atoms and missing side chain atoms and removing water molecules. The intermolecular interaction between compound 4 and caspase 9 was analyzed, and the key pharmacophore in the ligand was identified [10, 11] .
Statistical analysis
Data are presented as mean±SD. A one-way analysis of variance was used to determine the statistical significance of the results. In some cases, Student's t-test was used to compare two groups. The level of statistical significance was set at a P value less than 0.05.
Results
Isolation and identification of the compounds Alkannin (1) and angelylalkannin (3) were reported previously from the pigment fraction of A. tinctoria roots by partition between CHCl 3 and water [8] , and their structures were confirmed by their spectral data and compared with those reported previously [3, 4] . Other fractions were subjected to a series of column chromatographic separation to yield three novel compounds, named 5-methoxyangenylalkannin (4), alkanfuranol (7), and alkandiol (8), together with three known compounds, acetylalkannin (2) [11] , dimethylacryl alkannin (5) [12] , and arnebifuranone (6) [13] , respectively (Fig. 1) . The structures of the three novel compounds were elucidated on the basis of extensive spectroscopic evidence including high-resolution mass spectrometry and NMR spectra ( 1 H-, 13 C-, HMQC, HMBC, and COSY spectra). The detailed 1 H and 13 C data of the new compounds are provided in the Materials and methods section.
Compound 4, which was obtained as a red solid, yielded a quasimolecular ion peak at m/z 385.1653 [M + H] + in the high-resolution electrospray-ionization time-of-flight mass spectrometry (HRESITOFMS). The 1 H-NMR and 13 C-NMR spectra of 4 showed proton signals of two ortho-coupled and one singlet aromatic protons and two conjugated carbonyl groups, indicating that 4 belongs to the 1,4-naphthoquinone derivatives such as alkannin (1) . In addition, signals of an aromatic methoxy (5-OCH 3 ) were observed. Further analyses of 1 H-NMR and 13 C-NMR data suggested the presence of a 4-methylpent-3-en-1-ol side chain and an angenoyl group, which are similar to angelylalkannin (3) [12] . Further, the overall structure of 4, especially linkage sites, was assigned by 1 H-1 H COSY, HMQC, and HMBC. Having established the structure of 4, like alkannin (1), the absolute configuration of C-1 0 was assigned to be S using the optical rotation value [12] . Hence, the structure of 4 was identified as 5-methoxyangenylalkannin (1-[8-hydroxy-5-methoxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-4-methylpent-3-enyl angenyloate). Alkanfuranol (7) was obtained as a purple solid and had the molecular formula C 18 , and 138.9 (C-15)], and isoheptenyl moiety. The 1 H-NMR and 13 C-NMR data of 7 were similar to those of arnebifuranone (6) apart from the 3,4-dimethoxy-benzodihydroxyquinone moiety [13] . Further, the structure of 7 was confirmed by the COSY and HMBC spectra. Consequently, the structure of alkanfuranol (7) was established unambiguously as shown in Fig. 1 . H-NMR and 13 C-NMR data of 8 were quite similar to those of rhizonone, which was isolated from Lithospermum erythrorhizon (Boraginaceae), apart from the benzodihydroxyquinone moiety [14] . Further, the planar structure of 8 was confirmed by COSY and HMBC experiments. The 1 H-1 H COSY experiment on 8 indicated the presence of partial structures written in bold lines, and in the HMBC spectrum, the long-range correlations were observed between the following protons and carbons: H-5 and C-1,3; H-6 and C-2,4; H-7 and C-1,3,9; H-15 and C-8,10; and H-16 and C-8,12,14. Hence, the planar structure of alkandiol (8) was established as shown in Fig. 1 . The absolute stereochemistry of 8 has not been achieved yet, although its NOESY spectrum was recorded and the crosspeaks of H-7/H-8 and H-7/H-16 were observed. The occurrence of alkandiol (8) in A. tinctoria, the diol form of rhizonone, which is a novel metabolite putatively derived from geranylhydroquinone, has further suggested the similar biosynthesis pathway between alkannin and shikonin derivatives [14] [15] [16] .
Antiproliferative effects of eight compounds on HCT-116 and SW-480 cells compounds showed different antiproliferative effects on the two cancer cell lines. At the tested concentrations (3-50 mmol/l), compound 8 did not inhibit cancer cell growth on either of the two cancer cell lines. Compound 2 showed some antiproliferative effects on SW-480 cells, but such effects were not observed in HCT-116 cells. Compound 6 showed different potential for cancer cell growth inhibition.
In terms of the effects on HCT-116 cells, compounds 6 and 7 showed relatively weak antiproliferative effects, and at the concentration of 50 mmol/l, HCT-116 cell growth was inhibited by 91.7 and 92.5%, respectively (both P < 0.01 vs. control). Compounds 3 and 5 showed moderate effects; when treated with 30 mmol/l, the cancer cell growth was inhibited by 77.8 and 69.6%, respectively (both P < 0.01). Compounds 1 and 4 showed strong antiproliferative effects. At concentrations of 3 and 10 mmol/l, compound 1 inhibited cell growth by 29.7% (P < 0.05) and 59.3% (P < 0.01), whereas compound 4 inhibited cell growth by 43.1 and 77.4%, respectively (both P < 0.01). Compared with the other seven compounds, compound 4 showed the strongest antiproliferative effects on HCT-116 cells (Fig. 2a ). The IC 50 of compounds 1-8 on HCT-116 cells are 7.8, > 50, 16 .3, 4.4, 20.4, 34.6, 39.9, and >50 (mmol/l), respectively (Fig. 2c) .
Isolated compounds showed different antiproliferative effects on SW-480 cells (Fig. 2b) . However, the sensitivity of certain compounds on SW-480 cells was not similar to HCT-116 cells. Compounds 2 and 6 showed relatively weak antiproliferative effects; compound 5 showed a moderate effect; and compounds 1, 3, and 4 showed relatively strong effects, whereas compound 4 showed the strongest cancer cell inhibition effect on SW-480 cells (Fig. 2b) . The IC 50 of compounds 1-8 on SW-480 cells are shown in Fig. 2c . Data from both the HCT-116 and SW-480 cell lines suggested that the strongest antiproliferative effect was observed when using compound 4, a novel isolated compound.
Effects of eight compounds on cell cycle distribution of SW-480 cells
To examine whether proliferation in treated cells decreased because of cell cycle arrest at a specific phase, cell cycle profiles were determined using flow cytometry after staining with PI. As shown in Fig. 3 , besides compound 8, the other seven compounds induced cell cycle profile changes in different patterns. After treatment with 10 mmol/l of compounds 5 and 7, the SW-480 cells were arrested mainly in the G2/M phase. Compounds 1, 2, 3, 4, and 6 decreased the percentage of cells in the G1 phase and increased cell proportions in both the S and G2/M phases. S phase cells became a major group, especially in treatment with higher concentrations. Among the eight compounds, because compound 4 showed the most potent antiproliferative effect, and also possessed marked activity on S and G2/M phase arrest, the expressions of proteins that control S and G2/M phase transition were evaluated. Compared with the control, expressions of cyclin B1 and cdc2 were decreased in a dose-dependent manner. However, compound 4 significantly upregulated p21, while slightly increasing cdk2 (Fig. 3c ). Our results were consistent with the role of these proteins in the regulation of the S and G2/M phase transition [17, 18] . Data from this study suggest that those seven compounds arrested SW-480 cells in the S and G2/M phases, and compound 4 induced S and G2/M arrest through the modulation of cell cycle-regulating proteins.
Apoptotic induction effects of eight compounds on SW-480 cells
To explore the potential mechanism through which the tested compounds inhibit cell growth, cell apoptosis was assayed by flow cytometry after staining with double annexin V and PI in SW-480 cells (Fig. 4) . Annexin V can be detected in both the early and the late stages of apoptosis. PI enters the cell in late apoptosis or necrosis. Viable cells were negative for both annexin V and PI (lower left quadrant); early apoptotic cells were positive for annexin V and negative for PI (lower right quadrant); late apoptotic or necrotic cells showed both positive annexin V and PI (upper right quadrant); and nonviable cells that underwent necrosis were positive for PI and negative for annexin V (upper left quadrant). After treatment for 48 h, except for compounds 2, 5, 6, and 8, the other four compounds significantly induced cancer cell apoptosis at concentrations of 10 and 30 mmol/l (Fig. 4a) .
Compared with the control (5.1%), the percentages of cells in both early and late apoptosis for each compound (treatment with 10 and 30 mmol/l) were as follows: compound 1 (47.2%, 68.0%), compound 3 (38.9%, 83.2%), compound 4 (86.4%, 88.8%), and compound 7 (60.6%, 73.9%), respectively (all P < 0.01) (Fig. 4b) . This result suggests that the novel compound 4 has the most potent apoptotic induction activity. Caspase 3 and caspase 9 are two key proteins of the caspase family of proteases that are highly conserved in multicellular organisms and function as central regulators of apoptosis. They have been identified as playing a key role in the progression of apoptosis [19] [20] [21] . To further characterize the potential mechanism of the anticancer effect of compound 4, we performed caspase assays. As shown in Fig. 5a , treatment of SW-480 cells with 5 mmol/l of compound 4 for 24 h increased the protease activities of caspases 3 and 9. These activities were further increased when treated with 10 mmol/l of compound 4. At this treatment concentration, protease activity was increased by 85.2% for caspase 3 and 125.5% for caspase 9 (both P < 0.01 vs. control). However, treatment with 15 mmol/l did not increase their activities further (Fig. 5a ). The western blot assay supported our results obtained by the protease activity assay (Fig. 5b) .
As compound 4 significantly increased caspase 9 activity, to address whether compound 4 might interact physically with caspase 9, we examined compound 4 docking for human caspase 9. The Surflex-Dock program was used to predict the binding sites of compound 4 to caspase 9. The energetically most favorable position for compound 4 interaction with caspase 9 is shown in Fig. 5c . With insilico modeling, it is suggested that compound 4 forms hydrogen bonds with Asp-340 and Ser-339 at the active site of caspase 9 through its hydroxyl groups. In addition, compound 4 is predicted to show significant binding affinity for caspase 9 (CScore 3.82), suggesting that compound 4 directly interacts with caspase 9.
Discussion
Throughout the past two decades, the use of herbal medicines has been increasing in cancer patients [22, 23] .
As an alternative adjuvant to cancer chemotherapy, herbal medicines may act by increasing the sensitivity of neoplastic cells to chemotherapy and by reducing the toxic and adverse effects induced by chemotherapeutic agents, without interfering with their tumoricidal effects [24, 25] . It is known that botanicals have been a significant resource to several of the currently used efficacious chemotherapeutic agents [26, 27] . There needs to be a continued effort to tap this resource and explore botanical or herbal active components with novel, potent, and distinct anticancer actions [28, 29] .
Alkanna spp. is a genus of herbaceous plants including about 60 species of the family Boraginaceae. The major bioactive compounds isolated from Alkanna spp. plants are naphthoquinones [2] . Previous studies found that some naphthoquinone compounds showed anticancer activity [30, 31] , but information on the structuralfunctional relationship of this type of compound was limited.
In our recent preliminary study, we isolated two naphthoquinone compounds, alkannin and angelylalkannin, from A. tinctoria, and observed significant anticolorectal cancer cell proliferation activities. The antiproliferative potential of these two compounds was different, and the cancer cell inhibition of these two compounds was related to cell cycle arrest and induction of apoptosis. These promising data led us to further isolate compounds from this plant. In this study, eight naphthoquinone compounds were isolated and purified from A. tinctoria. Structural elucidation confirmed that three of them are novel compounds.
The antiproliferative effects of isolated compounds were determined using human colorectal cancer cells. The two cell lines used in this study have varied p53 expression. HCT-116 is p53 wild type, whereas SW-480 cells contain a p53 mutation. Cancer cells with p53 mutations are resistant to many chemotherapeutic agents [32] . Interestingly, we observed that compounds 2 and 7 showed higher antiproliferative abilities in the p53 mutant cell line (SW-480) than in the p53 wild type line (HCT-116), suggesting that special structural modifications might prove useful in p53-mutated colon cancers. Moreover, we observed that compound 4, a novel naphthoquinone compound, showed the most potent antiproliferative effect, and the antiproliferative effect of compound 4 is stronger than that of fluorouracil [33] , a commonly used chemotherapeutic agent.
Apoptosis is considered an important mechanism in the inhibition of cancer cells and many cancer chemotherapeutic agents are strong apoptotic inducers against cancer cells [34, 35] . In this study, we assayed the effect of eight compounds on cancer cell apoptosis and observed that the antiproliferation of potent compounds was related to their apoptotic response on colon cancer cells. To explore apoptotic induction mechanisms, we performed a caspase assay. We observed that compound 4 upregulated the expression of caspases 3 and 9, although this compound more significantly induced the expression of caspase 9. Apoptosis occurs through a complex signaling cascade that is regulated at multiple points and involves many proteins. Caspase 9 is situated at critical points in apoptotic pathways and as a result plays a central role in apoptosis signal transduction [36] . Our docking analysis suggested the existence of an interaction site between compound 4 and caspase 9. Compound 4-induced apoptosis may occur in part through direct interactions with this protein.
On the basis of chemical structures and observed biological activities, we explored the structure-activity relationships of these compounds. Of the eight compounds, six are alkannin derivatives. Among the six derivatives, alkannin (1) showed strong antiproliferative effects. When alkannin (1) was acetylated to form acetylalkannin (2), its antiproliferative effect was almost eliminated, in which IC 50 increased from 7.8 mmol/l (1) to greater than 50 mmol/l (2) (for HCT-116 cells, same as follows). Continued modification on the 1 0 -acetyl group led to an increase in the antiproliferative effect. Specifically, IC 50 decreased from greater than 50 mmol/l (acetylalkannin [2] ) to 20.4 mmol/l (dimethylacryl alkannin [5] ), and then to 17.0 mmol/l (angelylalkannin [3] ), but its antiproliferative potential was still less than that of alkannin (1). Further, when 5-OH of angelylalkannin (3) was methylated to form the novel compound 4 (5-methoxyangenylalkannin), antiproliferative activities were significantly increased, with an IC 50 of 4.4 mmol/l. These data suggested that 1 0 -OH modification decreased the antiproliferative effect, whereas modification on 5-OH increased its antiproliferative activity. Future structural modification should focus on 5-OH or 8-OH.
It is known that clinical drug development is a very long process and its success rate is low. However, many available anticancer drugs originated from natural pro-ducts. Our reported data are only an initial step for possible chemopreventive drug development. Compound 4 could have good chemopreventive potential with possible clinical implications as the compound inhibited human colon cancer growth. Future in-vivo pharmacological observations as well as pharmacokinetics and toxicity studies will be carried out.
Conclusion
We isolated eight compounds from A. tinctoria, with three novel compounds (compounds 4, 7, and 8). Among the eight compounds, six are alkannin derivatives, including compound 4. The antiproliferative activities of the eight compounds on different human colorectal cancer cell lines were determined. 5-Methoxyangenylalkannin (4) showed the most potent antiproliferative and apoptotic induction activities compared with alkannin (1) and its other derivatives. The analysis of the structural-functional relationship suggests that to improve anticancer activity, structural modification on alkannin should focus on hydroxyl groups at C-5 and C-8.
